Published in Pediatr Infect Dis J on January 01, 1994
Colonization and infection of the respiratory tract: What do we know? Paediatr Child Health (2004) 0.89
Treatment of group A streptococcal pharyngitis. Can J Infect Dis (1997) 0.87
Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. Antimicrob Agents Chemother (1998) 0.82
Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity. Clin Rheumatol (2014) 0.78
Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A beta-Hemolytic Streptococcus pharyngitis in Children. Int J Pediatr (2009) 0.76
Cephalosporins are more effective than penicillin in streptococcal pharyngitis. Pediatr Infect Dis J (1994) 2.19
Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J (1993) 1.28
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (1996) 21.81
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med (1999) 7.07
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med (1996) 6.14
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Declining blood lead levels and cognitive changes in moderately lead-poisoned children. JAMA (1993) 4.46
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet (1999) 4.36
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med (2000) 4.08
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79
A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65
HIV-1 drug resistance in newly infected individuals. JAMA (1999) 3.49
Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med (2001) 3.37
Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J Virol (1999) 3.15
Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96
Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet (1996) 2.81
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol (1997) 2.60
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med (1998) 2.50
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest (1999) 2.42
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med (1999) 2.33
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med Care (1969) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Evaluation of the effectiveness of comprehensive and continuous pediatric care. Pediatrics (1971) 2.22
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J Clin Invest (2000) 2.21
Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. Antimicrob Agents Chemother (1996) 2.13
The aetiological agent of cat scratch disease. Lancet (1985) 1.93
Resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother (1998) 1.92
Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr (1986) 1.89
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Micronitrous acid extraction-coagglutination test for rapid diagnosis of streptococcal pharyngitis. J Clin Microbiol (1983) 1.79
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74
Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr (1985) 1.73
Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy. J Infect Dis (1999) 1.70
Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol (1974) 1.70
Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. Health Soc Work (1998) 1.67
Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol (1973) 1.65
Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics (1999) 1.61
Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA (1997) 1.61
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60
Ritonavir and saquinavir combination therapy for the treatment of HIV infection. AIDS (1999) 1.58
Latex agglutination tests for rapid identification of group A streptococci directly from throat swabs. J Pediatr (1984) 1.56
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrob Agents Chemother (1997) 1.53
Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis (1992) 1.51
Why patients don't follow medical advice: a study of children on long-term antistreptococcal prophylaxis. J Pediatr (1969) 1.50
Studies in the epidemiology and preventability of rheumatic fever. IV. A quantitative determination of compliance in children on oral penicillin prophylaxis. Pediatrics (1969) 1.49
Culturing of throat swabs: end of an era? J Pediatr (1985) 1.45
Molecular and cellular pathology of hepatitis B. Lab Invest (1985) 1.43
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol (1993) 1.42
Tykes and bikes: injuries associated with bicycle-towed child trailers and bicycle-mounted child seats. Arch Pediatr Adolesc Med (2000) 1.39
Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy. J Virol (1998) 1.38
Distribution of five antigens in hepatocellular carcinoma. Lab Invest (1979) 1.35
Immune complexes in hepatocytic nuclei of HB ag-positive chronic hepatitis. N Engl J Med (1976) 1.35
A mail-in technique for detecting penicillin in urine: application to the study of maintenance of prophylaxis in rheumatic fever patients. Pediatrics (1968) 1.34
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection. J Infect Dis (2000) 1.26
Liver-directed gene transfer in non-human primates. Hum Gene Ther (1997) 1.25
Diagnosis of group A beta-hemolytic streptococcal pharyngitis. Use of antigen detection tests. Diagn Microbiol Infect Dis (1986) 1.24
Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance. Gastroenterology (1973) 1.23
Transfection of HepG2 cells with infectious hepatitis C virus genome. Am J Pathol (1997) 1.23
Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr (1985) 1.21
Eradication of rheumatic fever: an unfulfilled hope. Circulation (1970) 1.20
IgE in glomeruli of patients with nephrotic syndrome. Lancet (1971) 1.19
Five vs ten days of penicillin V therapy for streptococcal pharyngitis. Am J Dis Child (1987) 1.19
Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies. AIDS (1999) 1.18
Improved estimates for HIV-1 clearance rate and intracellular delay. AIDS (1999) 1.17
Incidence and circumstances of nonfatal firearm-related injuries among children and adolescents. Arch Pediatr Adolesc Med (2001) 1.13
Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy. Immunol Lett (1999) 1.12
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol (1983) 1.12
Periarteritis nodosa, Australia antigen and lymphatic leukemia. N Engl J Med (1972) 1.12
Exposure corrected risk estimates for childhood product related injuries. Accid Anal Prev (1993) 1.11
Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med (1985) 1.11
Detection of hepatitis B virus DNA in formalin-fixed, paraffin-embedded liver tissue by the polymerase chain reaction. Am J Pathol (1990) 1.11
Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance. J Virol (1998) 1.10
Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol (1986) 1.10
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics (1999) 1.10
Human immunodeficiency virus type-1 mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells. Virology (1997) 1.08
Immune response to hepatitis B virus in children with papular acrodermatitis. Gastroenterology (1977) 1.08
Child pedestrian injury taxonomy based on visibility and action. Accid Anal Prev (1995) 1.07
Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies. Proc Natl Acad Sci U S A (1980) 1.07
Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol (1981) 1.07
Sterilization of infant formula. Clin Pediatr (Phila) (1983) 1.07
Once daily therapy for streptococcal pharyngitis with cefadroxil. J Pediatr (1986) 1.07
The decline of rheumatic fever: role of medical intervention. Lewis W. Wannamaker Memorial Lecture. J Pediatr (1985) 1.06
Circadian rhythms of blood minerals in humans. Science (1981) 1.05
Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology (1993) 1.05
The treatment of pyoderma in children. JAMA (1970) 1.04
A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. N Engl J Med (1983) 1.04
New patterns of immunoglobulin deposition in the lesions of malignant nephrosclerosis, with special reference to IgE. Am J Pathol (1971) 1.04